Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
TB: 9 patent oppositions against J&Js overpriced drugs
News1.2 million lives were lost to TB last year. The reduction in TB deaths annually is slow, and even these...
Read more about TB: 9 patent oppositions against J&Js overpriced drugs
-
COVID-19 & TB: Why whether you live or die is a matter of justice, not science
OpinionJohnson & Johnson, a brand built on images of happy gurgling babies and the tagline ‘no more tears’, has the...
Read more about COVID-19 & TB: Why whether you live or die is a matter of justice, not science
-
HIV2020 video: Community reclaiming the global response!
NewsThe Treatment Activist Meeting took place last week, as part of HIV2020 Online. HIV2020 is described as a key population-led, inter-disciplinary,...
Read more about HIV2020 video: Community reclaiming the global response!
-
Join the #HIV2020 Activist Meeting – this Tuesday
NewsPlease join us at the HIV2020 Treatment Activist Meeting on Tuesday 6th October! Register by Sunday 4th October. The history of the HIV...
Read more about Join the #HIV2020 Activist Meeting – this Tuesday
-
HIV: Switch to generic darunavir in Kyrgyzstan and save $53,000
Call to action NewsFirst published by the Partnership Network Association in Kyrgyzstan, read here in Russian. Analysis carried out by our campaign partner,...
Read more about HIV: Switch to generic darunavir in Kyrgyzstan and save $53,000
-
Indian Patent Office: Merck’s patent application for HIV drug, raltegravir, is “refused”
NewsA patent that Merck has been pursuing in India since 2007 has been refused by the Indian Patent Office. The...
-
Petro: Providing the protection he didn’t have
InterviewWhen Petro was a teenager selling sex, HIV treatment didn’t exist, at least not as far as he was aware,...
Read more about Petro: Providing the protection he didn’t have
-
Russian patient organizations ask Gilead to disclaim patents for Truvada
Call to action NewsOn 3 September 2020, 25 patient organizations working within the HIV response in Russia published an open letter to Gilead...
Read more about Russian patient organizations ask Gilead to disclaim patents for Truvada
-
Breakthrough success as reformed patent law enters into force in Ukraine
News Press releaseUkraine’s reformed patent law provides a framework to prevent unlawful patents and monopolies on essential drugs, which have restricted access...
Read more about Breakthrough success as reformed patent law enters into force in Ukraine
-
Report: 10 years of community-monitoring of ARV procurement in Russia
News ResearchITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...
Read more about Report: 10 years of community-monitoring of ARV procurement in Russia
